MAP3K6
Reactivity: Human
Host: Rabbit
Polyclonal
FITC
Application Notes
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300,ELISA 1:5000,IF 1:50-200
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Expiry Date
12 months
Target
MAP3K6
(Mitogen-Activated Protein Kinase Kinase Kinase 6 (MAP3K6))
Alternative Name
MEK Kinase-6
Background
MAP3K6, ASK2, MAPKKK6, MEKK6, Mitogen-activated protein kinase kinase kinase 6, Apoptosis signal-regulating kinase 2MAP3K6 (mitogen-activated protein kinase kinase kinase 6) encodes a serine/threonine protein kinase that forms a component of protein kinase-mediated signal transduction cascades. The encoded kinase participates in the regulation of vascular endothelial growth factor (VEGF) expression. Alternative splicing results in multiple transcript variants.